"Cardiovascular Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Descriptor ID |
D002318
|
| MeSH Number(s) |
C14
|
| Concept/Terms |
Cardiovascular Diseases- Cardiovascular Diseases
- Cardiovascular Disease
- Disease, Cardiovascular
- Diseases, Cardiovascular
|
Below are MeSH descriptors whose meaning is more general than "Cardiovascular Diseases".
Below are MeSH descriptors whose meaning is more specific than "Cardiovascular Diseases".
This graph shows the total number of publications written about "Cardiovascular Diseases" by people in this website by year, and whether "Cardiovascular Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 2 | 3 |
| 1999 | 0 | 4 | 4 |
| 2000 | 4 | 2 | 6 |
| 2001 | 3 | 3 | 6 |
| 2002 | 8 | 2 | 10 |
| 2003 | 8 | 6 | 14 |
| 2004 | 8 | 4 | 12 |
| 2005 | 13 | 6 | 19 |
| 2006 | 6 | 9 | 15 |
| 2007 | 11 | 8 | 19 |
| 2008 | 17 | 7 | 24 |
| 2009 | 17 | 4 | 21 |
| 2010 | 14 | 9 | 23 |
| 2011 | 19 | 10 | 29 |
| 2012 | 18 | 8 | 26 |
| 2013 | 20 | 8 | 28 |
| 2014 | 25 | 5 | 30 |
| 2015 | 21 | 5 | 26 |
| 2016 | 19 | 6 | 25 |
| 2017 | 19 | 5 | 24 |
| 2018 | 25 | 5 | 30 |
| 2019 | 28 | 5 | 33 |
| 2020 | 29 | 4 | 33 |
| 2021 | 30 | 8 | 38 |
| 2022 | 26 | 0 | 26 |
| 2023 | 32 | 2 | 34 |
| 2024 | 15 | 7 | 22 |
| 2025 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cardiovascular Diseases" by people in Profiles.
-
Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults. JAMA Health Forum. 2025 Mar 07; 6(3):e245586.
-
Cardiometabolic disease risk in gorillas is associated with altered gut microbial metabolism. NPJ Biofilms Microbiomes. 2025 Feb 21; 11(1):33.
-
Cardiovascular events observed among patients in the etrasimod clinical programme: an integrated safety analysis of patients with moderately to severely active ulcerative colitis. BMJ Open Gastroenterol. 2025 Jan 08; 12(1).
-
TSH Trajectories During Levothyroxine Treatment in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) Cohort. J Clin Endocrinol Metab. 2024 Nov 18; 109(12):3065-3075.
-
Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis. Alzheimers Res Ther. 2024 Oct 16; 16(1):228.
-
Male Gender Expressivity and Diagnosis and Treatment of Cardiovascular Disease Risks in Men. JAMA Netw Open. 2024 Oct 01; 7(10):e2441281.
-
A Research Agenda to Improve Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2024 Sep 15; 210(6):715-729.
-
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial. JAMA Cardiol. 2024 Sep 01; 9(9):808-816.
-
Society for Cardiovascular Magnetic Resonance 2023 Cases of SCMR case series. J Cardiovasc Magn Reson. 2024 Winter; 26(2):101086.
-
Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trial. BMJ Open. 2024 08 07; 14(8):e078197.